Gynecology Book

http://www.fpnotebook.com/

Gonadotropin-releasing Hormone Agonist

Aka: Gonadotropin-releasing Hormone Agonist, GnRH agonist, Nafarelin Acetate, Synarel
  1. Indication
    1. Endometriosis
  2. Pathophysiology
    1. Potentiates Gonadotropin-releasing hormone (GnRH)
    2. Results in hypoestrogenism or pseudo-Menopause
    3. Does not cause the same androgenic effects as Danazol
  3. Dosing: Nafarelin Acetate (Synarel)
    1. Synarel 200-400 micro-g intranasally bid
  4. Efficacy
    1. Effective at regression of lesions and relief of pain
    2. No proven effect on fertility
  5. Adverse effects
    1. Menopausal symptoms
      1. Hot Flashes
      2. Insomnia
      3. Emotional changes
    2. Bone density loss with prolonged use

Synarel (C0131793)

Concepts Amino Acid, Peptide, or Protein (T116) , Pharmacologic Substance (T121)
MSH D017274
French Synarel
English synarel, Synarel
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree